Last 2,497 INR
Change Today +16.40 / 0.66%
Volume 6.7K
GLXO On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 08/27/14 All times are local (Market data is delayed by at least 15 minutes).

glaxosmithkline pharmaceutic (GLXO) Snapshot

Open
2,495
Previous Close
2,481
Day High
2,500
Day Low
2,474
52 Week High
03/3/14 - 3,055
52 Week Low
08/28/13 - 2,160
Market Cap
211.5B
Average Volume 10 Days
7.5K
EPS TTM
56.87
Shares Outstanding
84.7M
EX-Date
04/3/14
P/E TM
43.9x
Dividend
50.00
Dividend Yield
2.00%
Current Stock Chart for GLAXOSMITHKLINE PHARMACEUTIC (GLXO)

Related News

No related news articles were found.

glaxosmithkline pharmaceutic (GLXO) Related Businessweek News

No Related Businessweek News Found

glaxosmithkline pharmaceutic (GLXO) Details

GlaxoSmithKline Pharmaceuticals Limited operates as research-based healthcare and pharmaceutical company worldwide. It manufactures, distributes, and trades prescription medicines for a range of therapeutic areas, including analgesic, anti-infective, anti-inflammatory, anti-parasitic, cardiovascular, dermatology, diabetes, endocrine, gastrointestinal, gynaecology, immunosupressants, nutritional, respiratory, CNS, and oncology diseases. The company also offers vaccines for the prevention of various diseases comprising hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia, and others. GlaxoSmithKline Pharmaceuticals Limited was founded in 1924 and is based in Mumbai, India.

5,034 Employees
Last Reported Date: 03/20/14
Founded in 1924

glaxosmithkline pharmaceutic (GLXO) Top Compensated Officers

Managing Director, Executive Director and Mem...
Total Annual Compensation: 26.1M
Senior Executive Director of Finance, Senior ...
Total Annual Compensation: 14.3M
Executive Director of Technical and Executive...
Total Annual Compensation: 7.0M
Executive Director of Human Resources and Exe...
Total Annual Compensation: 7.2M
Compensation as of Fiscal Year 2013.

glaxosmithkline pharmaceutic (GLXO) Key Developments

GlaxoSmithkline Pharmaceuticals Limited Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

GlaxoSmithkline Pharmaceuticals Limited announced unaudited standalone earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported net sales of INR 6,549.6 million against INR 6,368.6 million a year ago. Profit from operations before other income and exceptional items were INR 1,092 million against INR 1,171.8 million a year ago. Profit from ordinary activities before tax was INR 1,490.4 million against INR 1,741 million a year ago. Net profit from ordinary activities was INR 982.9 million against INR 1,150.4 million a year ago. Basic and diluted earnings per share were INR 11.6 against INR 13.5 a year ago. For the six months, the company reported net sales of INR 12,548.1 million against INR 12,690 million a year ago. Profit from operations before other income and exceptional items were INR 2,125.5 million against INR 2,806.3 million a year ago. Profit from ordinary activities before tax was INR 2,972.7 million against INR 4,129.5 million a year ago. Net profit from ordinary activities was INR 1,948.3 million against INR 2,840.5 million a year ago. Basic and diluted earnings per share were INR 23 against INR 33.5 a year ago.

GlaxoSmithkline Pharmaceuticals Limited, Board Meeting, Aug 12, 2014

GlaxoSmithkline Pharmaceuticals Limited, Board Meeting, Aug 12, 2014. Agenda: To consider unaudited standalone earnings results for the second quarter and six months ended June 30, 2014.

GlaxoSmithkline Pharmaceuticals Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended March 31, 2014

GlaxoSmithkline Pharmaceuticals Limited reported unaudited standalone earnings results for the first quarter ended March 31, 2014. For the quarter, the company's net sales were INR 5,998.5 million against INR 6,321.4 million a year ago. Profit from operations before other income and exceptional items were INR 1,033.5 million against INR 1,634.5 million a year ago. Profit from ordinary activities before tax was INR 1,482.3 million against INR 2,388.5 million a year ago. Net profit from ordinary activities was INR 965.4 million or INR 11.4 per basic and diluted share against INR 1,690.1 million or INR 20.0 per basic and diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GLXO:IN 2,497.40 INR +16.40

GLXO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GLXO.
View Industry Companies
 

Industry Analysis

GLXO

Industry Average

Valuation GLXO Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PHARMACEUTIC, please visit www.gsk-india.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.